| Study title | A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled 3-Part Phase 3 Study to Demonstrate the Efficacy and Safety of Benralizumab in Patients with Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study) |
| Disease or condition | Eosinophilic Gastritis and/or Gastroenteritis |
| Study type | Interventional (Clinical Trial) |
| Intervention/treatment | Benralizumab or placebo |
| Phase | 3 |
| Study site | University of North Carolina at Chapel Hill |
| Study location | Chapel Hill |
| Principal investigator name and email | Evan Dellon, MD, MPH cedas@med.unc.edu |
| Study coordinator name and email | Tim Gee, timsgee@email.unc.edu |
| Phone contact | (919) 445-0747 |
| Clinicaltrials.gov link |